| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.0M | +48.0% |
| Cost of Revenue | $6.3M | +52.3% |
| R&D Expense | $339.5M | +12.7% |
| SG&A Expense | $180.3M | +15.0% |
| Operating Income | -$472.1M | -10.9% |
| Pre-tax Income | -$413.8M | -157.6% |
| Income Tax | -$1.0M | -102.3% |
| Net Income | -$412.8M | -161.3% |
| EPS (Basic) | -$7.12 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $89.1M | +16.9% |
| Inventory | $32.9M | +19.2% |
| Current Assets | $942.1M | -2.4% |
| Total Assets | $1.30B | -22.0% |
| Current Liabilities | $82.2M | +1.3% |
| Total Liabilities | $104.1M | -14.8% |
| Stockholders' Equity | $1.19B | -22.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$373.0M | +4.3% |
| Capital Expenditures | $4.3M | +156.1% |
| Investing Cash Flow | $377.2M | +3.8% |
| Financing Cash Flow | $8.7M | -39.9% |
| Free Cash Flow | -$377.3M | +3.6% |
| -160.0% |
| EPS (Diluted) | -$7.12 | -161.2% |